ITGB1 and neoplasm: This tendency was clearly present in TILs, where tumor animals treated with anti-CD29 antibody showed higher frequencies of CD8+IFN-γ+ T cells (∼20% versus ∼15% in controls) and CD8+GrzB+ T cells (∼15% versus ∼9% in controls) (Figure 6B, center and right plots).